razoxane has been researched along with Adult Premature Aging Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Franchitto, A; Oshima, J; Pichierri, P | 1 |
| Franchitto, A; Mosesso, P; Palitti, F; Pichierri, P | 1 |
2 other study(ies) available for razoxane and Adult Premature Aging Syndrome
| Article | Year |
|---|---|
The G2-phase decatenation checkpoint is defective in Werner syndrome cells.
Topics: Apoptosis; BRCA1 Protein; Cells, Cultured; DNA Damage; DNA Helicases; Exodeoxyribonucleases; Fibroblasts; G2 Phase; Genes, cdc; Humans; Mutation; Phosphorylation; Protein Processing, Post-Translational; Razoxane; RecQ Helicases; Topoisomerase II Inhibitors; Werner Syndrome; Werner Syndrome Helicase | 2003 |
Catalytic inhibition of topoisomerase II in Werner's syndrome cell lines enhances chromosomal damage induced by X-rays in the G2 phase of the cell cycle.
Topics: Catalysis; Cell Line; Chromosome Aberrations; DNA Damage; G2 Phase; Humans; Razoxane; Topoisomerase II Inhibitors; Werner Syndrome; X-Rays | 2000 |